ADAR1 Capital Management, LLC significantly increased its ownership stake in Tenax Therapeutics, Inc. (NASDAQ:TENX).
The firm purchased 770,333 shares on September 2, 2026. These shares were acquired at a price of $1.79 each. ADAR1 purchased an additional 900,000 shares on September 3, 2026. This second transaction totaled approximately $1.6 million.
The firm now holds a total of 5,624,151 shares. This position represents a 15.03% ownership stake in the company.
Tenax is currently navigating late-stage clinical development for its pipeline. The company will present at the Cantor Global Healthcare Conference on September 9, 2026. The stock has reacted positively since the initial transaction date.